Cardiogenic shock: therapy and prevention

Clinical Cardiology
W L Barry, I J Sarembock


Cardiogenic shock is defined as profound circulatory failure resulting in insufficient tissue perfusion to meet resting metabolic demands. It occurs in approximately 7.5% of patients with acute myocardial infarction. Treatment strategies include inotropic agents, use of intra-aortic balloon counterpulsation, and revascularization. Current evidence supports the use of primary angioplasty. Surgery should be considered in patients with triple-vessel disease. If early catheterization is not available, thrombolytic therapy should be given to eligible patients and transfer to an interventional facility should be considered. Effective therapy for shock must also include a prevention strategy. This requires identification of patients at high risk for shock development and selection of patients who are candidates for aggressive intervention.


Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·M Rihner, R W Smalling
Nov 26, 2009·The Annals of Thoracic Surgery·Igor D GregoricBiswajit Kar
Oct 24, 2013·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·L TangC W Binns


Mar 1, 1978·The American Journal of Cardiology·A L GutovitzR Roberts
Dec 1, 1992·Journal of the American College of Cardiology·J R BengtsonR M Califf
Mar 11, 1992·Journal of the American College of Cardiology·M D HibbardB J Gersh
Apr 1, 1992·Journal of the American College of Cardiology·A R MoosviS Goldstein
Mar 1, 1991·Journal of the American College of Cardiology·L LeeW W O'Neill
May 10, 1973·The New England Journal of Medicine·S ScheidtA Kantrowitz
Apr 1, 1982·The American Journal of Cardiology·R S GibsonR P Martin
Oct 1, 1994·The American Journal of Cardiology·M J Domanski, E J Topol
Aug 1, 1993·Bratislavské lekárske listy·J MurínR Uhliar
Sep 8, 1994·The New England Journal of Medicine·J W Hurst
Apr 28, 1994·The New England Journal of Medicine·J W Kinch, T J Ryan
Jun 16, 1994·The New England Journal of Medicine·R M Califf, J R Bengtson
Dec 1, 1993·Circulation·M L Simoons, A E Arnold
Jan 15, 1994·The American Journal of Cardiology·N F ColR J Goldberg
Mar 20, 1997·The New England Journal of Medicine·R CollinsP Sleight

Related Concepts

Metabolic Process, Cellular
Myocardial Contraction
Treatment Protocols
Glucocorticoid Deficiency With Achalasia
Ventricular Dysfunction, Left
Myocardial Infarction
Inotropic agent
Intra-Aortic Balloon Pumping

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.